Moberg Pharma AB (OSTO:MOB) Additional Paid-In Capital : kr921.92 Mil(As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB Additional Paid-In Capital?

Moberg Pharma AB's quarterly additional paid-in capital increased from Sep. 2023 (kr920.88 Mil) to Dec. 2023 (kr921.30 Mil) and increased from Dec. 2023 (kr921.30 Mil) to Mar. 2024 (kr921.92 Mil).

Moberg Pharma AB's annual additional paid-in capital increased from Dec. 2021 (kr731.38 Mil) to Dec. 2022 (kr841.20 Mil) and increased from Dec. 2022 (kr841.20 Mil) to Dec. 2023 (kr921.30 Mil).

Moberg Pharma AB Additional Paid-In Capital Historical Data

The historical data trend for Moberg Pharma AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Additional Paid-In Capital Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

528.12

731.38

841.20

921.30

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															841.68	842.26	920.88	921.30	921.92

Moberg Pharma AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Moberg Pharma AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (OSTO:MOB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

MOBs:UK MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.